Threshold Pharmaceuticals | search
Click here to view Threshold Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Molecular Templates Completes Merger with Threshold ...Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements. Download as PDF August 02, 2017 8:30am EDT. Combined Company Has a Unique Biological Platform with a Differentiated Mechanism of Action in Oncology and Two Clinical-Stage Candidates, MT-3724 and Evofosfamide. Combined Company to Commence Trading on The ...
- Threshold Pharmaceuticals Announces Its Two Phase 3 Studies ...Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of...
- Threshold Pharmaceuticals, Inc. Stock Nasdaq - MarketScreener.comThreshold Pharmaceuticals, Inc. (ZB_4706838.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Threshold Pharmaceuticals, Inc. | Nasdaq: | Nasdaq a20430a08f74dfa229b.cpd1o5ZeQINmtTmQYLLZWABjGDdmZZUIira5wUNgoWw.AbpB1_ttEdIWwnLKKuiLLWgbSF1QSOZezNTjkHo4xlU65gXh4zUI-V6HTg
- Threshold Pharmaceuticals Announces Its Two Phase 3 Studies ...Threshold Pharmaceuticals, Inc. today announced the outcomes of two Phase 3 cancer studies of evofosfamide , an investigational hypoxia-activated prodrug, which is being evaluated for...
- Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By ...Threshold first hit the radar at $3, then at $5, and has traded recently as high as $9.00 on Orphan Drug status and continued success. They are a development stage company and have a very good ...
More
